---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-025669"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2026-06-18T12:15:34+00:00"
generated_at: "2026-06-18T12:20:13.791604+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Grace Therapeutics updates corporate presentation; no specific details available in filing

## Summary
- Filed updated corporate presentation as Exhibit 99.1 dated June 17, 2026.
- Presentation content not fully included in the filing; unable to assess material changes.
- No financial or operational metrics disclosed in the 8-K body.

## SEC filing metadata
- accession: 0001140361-26-025669
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2026-06-18T12:15:34+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000114036126025669/0001140361-26-025669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000114036126025669/ef20076431_form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-025669
- JSON: https://secwatch.observer/filing/0001140361-26-025669.json
- Plain text: https://secwatch.observer/filing/0001140361-26-025669.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.